Clinical Trial Update: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating metformin as a novel therapy for autosomal dominant polycystic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Kyongtae Ty Bae, M.D., Ph.D. | Conditions: Polycystic Kidney, Autosomal Dominant | Phase 2 | Status: COMPLETED | Results posted: 2022-08-09